Navigation Links
CSL Behring Receives FDA Orphan Drug Designation for rVIIa-FP, a Novel Therapy in Development to Treat Hemophilia A and Hemophilia B Patients Who Have Inhibitors
Date:2/16/2012

ases that affect fewer than 200,000 people in the U.S. Orphan designation qualifies the sponsor of the product for important tax credits, elimination of FDA license application fees and certain marketing incentives.

CSL Behring's rVIIa-FP was granted Orphan Drug Designations (ODD) by the European Commission in May, 2011.

About Hemophilia
Hemophilia is a congenital bleeding disorder characterized by prolonged or spontaneous bleeding, especially into the muscles, joints, or internal organs. In nearly all cases, it affects only males. The disease is caused by deficient or defective blood coagulation proteins known as factor VIII or IX. The most common form of the disease is hemophilia A, or classic hemophilia, in which the clotting factor VIII is either deficient or defective.  Hemophilia B is characterized by deficient or defective factor IX. Hemophilia A affects approximately 1 in 5,000 to 10,000 people. Hemophilia B affects approximately 1 in 25,000 to 50,000 people. The recommended treatment for patients who are factor deficient is to treat by replacement factor therapy. A complication in some patients is the development of inhibitory antibodies (inhibitors) to FVIII or FIX which renders replacement therapy ineffective.  This can occur in up to 25 percent of hemophilia A patients and around 5 percent of hemophilia B patients.  One treatment option for these patients is recombinant activated factor VII (called a bypassing agent) which can be used to achieve hemostasis without the need for factor VIII or IX. 

About the recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP)
Preclinical studies have confirmed that CSL Behring's rVIIa-FP has favorable pharmacokinetic properties compared with the existing recombinant FVIIa product.
'/>"/>

SOURCE CSL Behring
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CSL Behring Receives FDA Approval of Expanded Label on Berinert® for Self-administration and Treatment of Acute Laryngeal Attacks of Hereditary Angioedema
2. CSL Behring Seeks Proposals for Interlaken Leadership Awards, Supporting Innovative Research Into Neuroimmunology
3. CSL Behring Receives EU Orphan Drug Designations for rVIIa-FP for Hemophilia A and B Treatment
4. National Organization for Rare Disorders Presents CSL Behring With 2011 Corporate Award
5. CSL Behring Marks World Hemophilia Day with Coagulation Factor Donation to World Federation of Hemophilia
6. CSL Behring Medical Product Donation Helps Meet Critical Need for Ongoing Cholera Relief Effort in Haiti
7. CSL Behring Announces Completion of National Marketing Authorizations of Berinert® After MRP in 23 European Countries
8. CSL Behring Announces FDA Approval of Berinert(R), First and Only Therapy Approved for the Treatment of Acute Abdominal and Facial Attacks of Hereditary Angioedema in U.S.
9. CSL Behring Receives Orphan-Drug Exclusivity for RiaSTAP(TM), First and Only Approved Treatment of Acute Bleeding Episodes in Patients with Congenital Fibrinogen Deficiency
10. Over $10 Million of CSL Behrings Privigen Was Sold in the U.S. During the Third Quarter of 2008
11. CSL Behring Submits BLA Requesting Approval of C1-Esterase Inhibitor for the Treatment of Hereditary Angioedema
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... YORK , Sept. 30, 2014 The ... stage. Both established medical-device providers as well as new ... European region, while simultaneously looking at ways to reduce ... sector. Using distributors is one of the effective means ... medical devices distribution market in Eastern European and provides ...
(Date:9/30/2014)... NEW YORK , Sept. 30, 2014 /PRNewswire/ ... collaboration, according to a new report from Kalorama ... 100 deals had occurred in proteomics in the ... and IPOs, to agreements between private proteomic companies ... biotech companies with novel proteomics innovator companies.  Kalorama ...
(Date:9/30/2014)... , Sept. 30, 2014 Passport Health, ... America , has launched FluFree.com, a website designed ... vaccinations. For 20 years, Passport Health has ... the flu. The launch of FluFree.com is designed to ... and the number of people who actually chose to ...
Breaking Medicine Technology:Medical Technologies Distributor Profiles in Eastern Europe 2Medical Technologies Distributor Profiles in Eastern Europe 3Report: Race for Proteomics Knowledge Spurs Investment and Partnerships 2Report: Race for Proteomics Knowledge Spurs Investment and Partnerships 3Passport Health Launches FluFree.com - Aims To Improve Flu Vaccination Rates and Fulfill Growing Public Health Priority 2Passport Health Launches FluFree.com - Aims To Improve Flu Vaccination Rates and Fulfill Growing Public Health Priority 3
... One of China,s Most Influential Companies -- Announces Repurchase ... 20 American Dairy, Inc. (NYSE Arca: ADY), one ... formula, milk powder and soybean, rice and walnut products ... continues to increase its production output and customer support ...
... HOLLYWOOD, Fla., Jan. 19 A new approach to ... less down time, lower costs and less risk overall, ... at the 21st annual International Symposium on Endovascular Therapy ... angioplasty over bypass surgery to open their blocked arteries. ...
Cached Medicine Technology:American Dairy Provides Business Update 2American Dairy Provides Business Update 3American Dairy Provides Business Update 4American Dairy Provides Business Update 5American Dairy Provides Business Update 6Wrist Access Safer, Easier for Many Patients Undergoing Minimally Invasive Treatment of Blocked Heart Arteries 2
(Date:9/30/2014)... no genetic evidence that high levels of vitamin D ... Some previous research had suggested that elevated levels ... diabetes, raising the possibility of a link between vitamin ... this study, British researchers investigated the association between diabetes ... control blood levels of vitamin D. They found no ...
(Date:9/30/2014)... 2014 (HealthDay News) -- Children conceived either less than one ... a sibling could be at increased risk for autism, a ... and an outside expert agree that the research can,t prove ... "Most importantly, it is important that parents understand that the ... are close together or far apart," said outside expert Dr. ...
(Date:9/30/2014)... to cut climate-changing carbon emissions will reduce other ... benefits, according to a new study released today. ... options included in the final Clean Power Plan, ... premature deaths and hospitalizations, and hundreds of heart ... the new study, Health Co-benefits of Carbon Standards ...
(Date:9/30/2014)... By Alan Mozes ... 2014 (HealthDay News) -- Colon cancer patients who are ... slightly higher risk for developing a second weight-related cancer, ... to the risk of colon cancer recurrence, only the ... , "We found that colorectal cancer survivors who reported ...
(Date:9/30/2014)... lung cancer, breast cancer is the leading cause of ... Society. That,s why so many medical professionals encourage women ... at best: only a minority of suspicious mammograms actually ... lots of needless worry for women and their familiesnot ... tests, including ultrasounds and biopsies. , Recently, a ...
Breaking Medicine News(10 mins):Health News:Gene Study Finds No Proof Vitamin D Guards Against Type 2 Diabetes 2Health News:Spacing Between Sibling Births Tied to Autism Risk in Study 2Health News:Power plant standards could save thousands of US lives every year 2Health News:Power plant standards could save thousands of US lives every year 3Health News:Obesity Tied to Higher Cancer Risk for Colon Cancer Survivors 2Health News:Obesity Tied to Higher Cancer Risk for Colon Cancer Survivors 3Health News:'Virtual breast' could improve cancer detection 2
... new office to better serve their clients. , ... (PRWEB) September 11, ... the opening of their new office in Dallas. The new branch,s address ... currently receiving patients for eye care and eye wear. , , ,The ...
... the,Pennsylvania smoking ban will filter into public places., ... make their homes and cars,smoke-free too," said Jennifer Ibrahim, ... co-author of a recent report on smoking bans in ... She and her colleagues reviewed the global body ...
... SECOND PROGRESS REPORT SHOWS BEVERAGE CALORIES SHIPPED TO ... 10 A new report released,today shows that ... schools two years into a three-year implementation period ... a Healthier,Generation, a joint initiative of the William ...
... Cross and,Blue Shield and its broker partner, Liberty Insurance, ... to answer common health insurance,questions on Wednesday, September 10, ... phone bank and get their question answered., The ... will take calls,from 3:00 to 7:00 p.m. Consumers can ...
... 10 Ellex Medical Lasers,Limited (ASX: ELX) today ... the establishment of a direct sales channel in ... launched at the European Society of Cataract and,Refractive ... Ellex,Deutschland GmbH will focus initially on sales of ...
... Sept. 10 The SSI Group, Inc. (SSI),announced ... to offer a,Claims Management Solutions through SSI,s ClickON(R), ... LinX offering will enable Siemens Healthcare customers,to take ... including Claims Editing,and Transmission, Claim Status, Secondary Billing, ...
Cached Medicine News:Health News:Northeastern Eye Institute Opens New Office 2Health News:PA's Smoking Ban Should Filter Into Homes and Cars Too, According to Temple University Expert 2Health News:Beverage Industry Continues Cutting Calories in Schools, Delivering on Its Commitment to Change Beverage Mix 2Health News:Beverage Industry Continues Cutting Calories in Schools, Delivering on Its Commitment to Change Beverage Mix 3Health News:Beverage Industry Continues Cutting Calories in Schools, Delivering on Its Commitment to Change Beverage Mix 4Health News:Ellex Commences Direct Sales in Germany 2Health News:SSI Announces Agreement with Siemens Healthcare 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: